Edwards Lifesciences cut to underperform at Bernstein as organic growth slows
- ByInvesting.com-
By Sam Boughedda Bernstein analysts double downgraded Edwards Lifesciences (NYSE:EW) to Underperform from Outperform on Tuesday, cutting the firm's price target on the stock to $66...